Feb 2, 2026 04:48PM Pelthos Therapeutics (PTHS) files $200M mixed shelf

Jan 15, 2026 04:10PM Horizon Technology provides $50 million loan facility to Pelthos

Jan 13, 2026 08:31AM Pelthos Therapeutics secures $50 million credit facility from Horizon

Jan 5, 2026 07:30AM Pelthos Therapeutics acquires Xeglyze head lice treatment for $1.8 million

Jan 2, 2026 04:50PM Pelthos acquires head lice treatment assets for $1.8 million

Dec 23, 2025 06:00PM Pelthos Therapeutics appoints Andrew Einhorn to board of directors

Dec 4, 2025 07:02AM Pelthos signs pharmacy benefit manager deal for molluscum treatment

Dec 3, 2025 06:07AM H.C. Wainwright Starts Pelthos Therapeutics (PTHS) at Buy

Nov 25, 2025 03:19AM Roth/MKM Starts Pelthos Therapeutics (PTHS) at Buy

Nov 14, 2025 07:06AM Pelthos Therapeutics (PTHS) PT Raised to $57 at Oppenheimer

Nov 13, 2025 06:47AM Pelthos Therapeutics Inc. (PTHS) reported Q3 result

Nov 7, 2025 08:01AM Pelthos Therapeutics acquires Xepi cream and raises $18 million

Oct 9, 2025 08:01AM Pelthos launches patient advocacy campaign for molluscum skin infection

Sep 2, 2025 06:04AM Oppenheimer Starts Pelthos Therapeutics (PTHS) at Outperform

Aug 18, 2025 04:47PM Pelthos Therapeutics Inc. (PTHS) Reports Q2 Loss of $5.38

Jul 2, 2025 07:01AM Ligand Pharma (LGND) Announces Completion of Pelthos Therapeutics Merger with Channel Therapeutics